Etiology, pathophysiology, and treatment of atrial fibrillation: part 1.
about
Atrial Fibrillation: The Science behind Its DefianceHypoxic hepatitis and acute liver failure in a patient with newly onset atrial fibrillation and diltiazem infusionTreatment of systemic hypertension.Current approaches to the treatment of hypertension in older persons.Diminished responsiveness to dobutamine as an inotrope in mice with cecal ligation and puncture-induced sepsis: attribution to phosphodiesterase 4 upregulation.
P2860
Etiology, pathophysiology, and treatment of atrial fibrillation: part 1.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Etiology, pathophysiology, and treatment of atrial fibrillation: part 1.
@ast
Etiology, pathophysiology, and treatment of atrial fibrillation: part 1.
@en
type
label
Etiology, pathophysiology, and treatment of atrial fibrillation: part 1.
@ast
Etiology, pathophysiology, and treatment of atrial fibrillation: part 1.
@en
prefLabel
Etiology, pathophysiology, and treatment of atrial fibrillation: part 1.
@ast
Etiology, pathophysiology, and treatment of atrial fibrillation: part 1.
@en
P1433
P1476
Etiology, pathophysiology, and treatment of atrial fibrillation: part 1.
@en
P2093
Wilbert S Aronow
P304
P356
10.1097/CRD.0B013E31816DE1E3
P577
2008-07-01T00:00:00Z